Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens

Summary Hepatitis C virus (HCV) chronically infects 2%‐3% of the world's population, causing liver disease and cancer with prolonged infection. The narrow host range of the virus, being restricted largely to human hepatocytes, has made the development of relevant models to evaluate the efficacy...

Ausführliche Beschreibung